Annual Accounts Payable
$4.00 M
-$458.00 K-10.27%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual accounts payable is $4.00 million, with the most recent change of -$458.00 thousand (-10.27%) on December 31, 2023.
- During the last 3 years, MRNS annual accounts payable has risen by +$1.79 million (+81.05%).
- MRNS annual accounts payable is now -10.27% below its all-time high of $4.46 million, reached on December 31, 2022.
Performance
MRNS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.71 M
-$2.53 M-40.56%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly accounts payable is $3.71 million, with the most recent change of -$2.53 million (-40.56%) on September 30, 2024.
- Over the past year, MRNS quarterly accounts payable has stayed the same.
- MRNS quarterly accounts payable is now -40.56% below its all-time high of $6.24 million, reached on June 30, 2024.
Performance
MRNS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MRNS Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -10.3% | 0.0% |
3 y3 years | +81.0% | -16.9% |
5 y5 years | +61.9% | -16.9% |
MRNS Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -10.3% | +28.1% | -40.6% | +61.0% |
5 y | 5-year | -10.3% | +81.0% | -40.6% | +434.9% |
alltime | all time | -10.3% | +5032.1% | -40.6% | +4652.6% |
Marinus Pharmaceuticals Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $3.71 M(-40.6%) |
Jun 2024 | - | $6.24 M(+1.8%) |
Mar 2024 | - | $6.13 M(+53.0%) |
Dec 2023 | $4.00 M(-10.3%) | $4.00 M(+52.4%) |
Sep 2023 | - | $2.63 M(+14.1%) |
Jun 2023 | - | $2.30 M(-48.5%) |
Mar 2023 | - | $4.47 M(+0.1%) |
Dec 2022 | $4.46 M(+42.7%) | $4.46 M(+57.7%) |
Sep 2022 | - | $2.83 M(-14.2%) |
Jun 2022 | - | $3.30 M(-29.4%) |
Mar 2022 | - | $4.67 M(+49.4%) |
Dec 2021 | $3.13 M(+41.4%) | $3.13 M(+351.1%) |
Sep 2021 | - | $693.00 K(-79.1%) |
Jun 2021 | - | $3.31 M(-35.9%) |
Mar 2021 | - | $5.17 M(+133.7%) |
Dec 2020 | $2.21 M(-20.0%) | $2.21 M(-26.3%) |
Sep 2020 | - | $3.00 M(-19.7%) |
Jun 2020 | - | $3.73 M(+31.2%) |
Mar 2020 | - | $2.85 M(+3.0%) |
Dec 2019 | $2.76 M | $2.76 M(-22.4%) |
Sep 2019 | - | $3.56 M(-28.4%) |
Jun 2019 | - | $4.97 M(+157.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $1.93 M(-21.8%) |
Dec 2018 | $2.47 M(+166.7%) | $2.47 M(-15.3%) |
Sep 2018 | - | $2.92 M(+125.4%) |
Jun 2018 | - | $1.29 M(+62.4%) |
Mar 2018 | - | $797.00 K(-14.0%) |
Dec 2017 | $927.00 K(-67.0%) | $927.00 K(+46.2%) |
Sep 2017 | - | $634.00 K(-45.4%) |
Jun 2017 | - | $1.16 M(-48.1%) |
Mar 2017 | - | $2.24 M(-20.4%) |
Dec 2016 | $2.81 M(-10.7%) | $2.81 M(-26.9%) |
Sep 2016 | - | $3.85 M(+36.2%) |
Jun 2016 | - | $2.82 M(+10.6%) |
Mar 2016 | - | $2.55 M(-18.8%) |
Dec 2015 | $3.15 M(+486.9%) | $3.15 M(+36.8%) |
Sep 2015 | - | $2.30 M(+109.7%) |
Jun 2015 | - | $1.10 M(-64.1%) |
Mar 2015 | - | $3.06 M(+470.0%) |
Dec 2014 | $536.00 K(+587.2%) | $536.00 K(-35.2%) |
Sep 2014 | - | $827.30 K(-52.5%) |
Jun 2014 | - | $1.74 M(-1.7%) |
Mar 2014 | - | $1.77 M(+2172.6%) |
Dec 2013 | $78.00 K(-32.2%) | $78.00 K |
Dec 2012 | $115.10 K | - |
FAQ
- What is Marinus Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual accounts payable year-on-year change?
- What is Marinus Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly accounts payable year-on-year change?
What is Marinus Pharmaceuticals annual accounts payable?
The current annual accounts payable of MRNS is $4.00 M
What is the all time high annual accounts payable for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual accounts payable is $4.46 M
What is Marinus Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, MRNS annual accounts payable has changed by -$458.00 K (-10.27%)
What is Marinus Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of MRNS is $3.71 M
What is the all time high quarterly accounts payable for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly accounts payable is $6.24 M
What is Marinus Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, MRNS quarterly accounts payable has changed by $0.00 (0.00%)